Monoclonal antibodies are synthetic molecules manufactured in the lab. But do we need them if a vaccine is on its way?
Death rates for hospitalized COVID-19 patients fell from 25.6% in March to 7.6% in August, according to a new study on three hospitals in New York. A study in the U.K. found similar results.
The global pandemic has fueled illicit online sales of COVID-19 commodities, some of which are dangerous or illegal. Researchers are assessing the size and reach of this underground market.
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they're available to all.
During the last six months, news reports have mentioned dozens of drugs that may be effective against the new coronavirus. Here we lay out the evidence and reveal which ones are proven to work. Or not.
Gilead's drug Remdesivir showed preliminary positive results in clinical trials. But what is this drug and how, exactly, does it work?
Vaccines for other diseases are being examined for their protective effects against coronavirus.
As the pandemic intensifies, Harvard scientists work to find a treatment.
/
2
